Related Experiment Video

Updated: Mar 21, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.9K

Quercetin induces bladder cancer cells apoptosis by activation of AMPK signaling pathway

Qiongli Su1, Mei Peng1, Yuqing Zhang2

  • 1Department of Pharmacy, School of Medicine, Hunan Normal University Changsha 410013, Hunan, P. R. China.

American Journal of Cancer Research
|May 18, 2016
PubMed

Insights

Quercetin, a natural compound, shows promise in inhibiting bladder cancer by activating the AMPK pathway. This study reveals its potential anticancer mechanisms, including apoptosis induction and migration inhibition.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Quercetin, a polyphenol, exhibits anticancer properties against various carcinomas but lacks clinical approval due to unclear mechanisms.
  • Bladder cancer is a prevalent malignancy globally, with a high incidence rate in China.
  • The anticancer effects of quercetin on bladder cancer remain unexplored.

Purpose of the Study:

  • To investigate the underlying mechanisms of quercetin's inhibitory effects on bladder cancer.
  • To evaluate quercetin's potential as a therapeutic agent for bladder cancer.

Main Methods:

  • In vitro testing of quercetin's inhibitory sensitivity on human and murine bladder cancer cell lines using MTT and colony formation assays.
  • Western blot analysis to examine the involvement of the AMPK signaling pathway, including 4E-BP1 and S6K.

Main Results:

  • Quercetin demonstrated significant inhibition of bladder cancer cell proliferation and migration.
  • The study identified quercetin's activation of the AMPK pathway as a key mechanism of action.
  • Quercetin was found to induce apoptosis in bladder cancer cells.

Conclusions:

  • Quercetin exhibits potent anticancer activity against bladder cancer cells.
  • Activation of the AMPK pathway is a crucial mechanism underlying quercetin's efficacy.
  • Further research into quercetin's therapeutic potential for bladder cancer is warranted.
Keywords:
AMPKQuercetinbladder cancer

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.0K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K